Alzheimer disease therapeutics: Perspectives from the developing world

Journal of Alzheimer's Disease

Volumn 15, Issue 2, 2008, Pages 285-287

  Shafqat, Saad ^a  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

Author keywords

Constraints; Cultural; Economic; Social

Indexed keywords

DONEPEZIL; GALANTAMINE; MEMANTINE; RIVASTIGMINE; TACRINE;

ALZHEIMER DISEASE; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HEALTH EDUCATION; HUMAN; PAKISTAN; PATIENT CARE; PRIORITY JOURNAL; SHORT SURVEY; SOCIOECONOMICS;

EID: 54249154649     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-15211     Document Type: Short Survey

References (11)

1. S.P. Agarwal, Health sector in India - progress, challenges and the way forward, J Indian Med Assoc 103 (2005), 692-698.
2. G.F. Anderson and E. Chu, Expanding priorities - confronting chronic disease in countries with low income, N Engl J Med 356 (2007), 209-211.
3. J. Birks, Cholinesterase inhibitors for Alzheimer's disease, Cochrane Database Syst Rev 1 (2006), CD005593.
4. M. Day, NICE says anti-dementia drugs should be used only for moderate Alzheimer's disease, BMJ 333 (2006), 774.
5. C.P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, M. Ganguli, K. Hall, K. Hasegawa, H. Hendrie, Y. Huang, A. Jorm, C. Mathers, P.R. Menezes, E. Rimmer and M. Scazufca, Global prevalence of dementia: a Delphi consensus study, Lancet 366 (2005), 2112-2117.
6. S. Nishtar, The Gateway Paper - preventive and promotive programs in Pakistan and health reforms in Pakistan, J Pak Med Assoc 56 (2006), S51-S65.
7. V. Patel, Promoting mental health in developing countries, Lancet 370 (2007), 821.
8. M. Prince, V. Patel, S. Saxena, M. Maj, J. Maselko, M.R. Phillips and A. Rahman, No health without mental health, Lancet 370 (2007), 859-877.
9. P. Raina, P. Santaguida, A. Ismaila, C. Patterson, D. Cowan, M. Levine, L. Booker and M. Oremus, Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline, Ann Intern Med 148 (2008), 379-397.
10. G. Thornicroft and S. Maingay, The global response to mental illness, BMJ 325 (2002), 608-609.
11. D. Yach, C. Hawkes, C.L. Gould and K.J. Hofman, The global burden of chronic diseases: overcoming impediments to prevention and control, JAMA 291 (2004), 2616-2622.